Jubilant Pharma

Technetium-99m Market Size to Reach USD 6.29 Billion by 2031, Growing at a CAGR of 3.9% | Exclusive Report by The Insight Partners

Jubilant Pharma arm to raise USD 400 million loan from Standard Chartered Bank to repay debt

JUBILANT PHARMA LIMITED

Dyslexia Treatment Market Expected to Achieve 7.10% CAGR, Reaching 62.26 Billion USD by 2032

Senior Manager, Business Development

Jubilant Pharma Limited is a well-established member of the business community, providing a complete range of services to support the pharmaceutical and biopharmaceutical industries. The Senior Manager, Business Development engages in direct sales and marketing efforts, focusing on developing new client relationships and sales strategies for West coast locations in California, Oregon, and Washington.

Sign up with Google

Sign in with Google